108 related articles for article (PubMed ID: 12764435)
21. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein.
Ugen KE; Srikantan V; Goedert JJ; Nelson RP; Williams WV; Weiner DB
J Infect Dis; 1997 Jan; 175(1):63-9. PubMed ID: 8985197
[TBL] [Abstract][Full Text] [Related]
22. Human immunodeficiency virus V3 peptide-reactive antibodies are present in normal HIV-negative sera.
Metlas R; Trajkovic D; Srdic T; Veljkovic V; Colombatti A
AIDS Res Hum Retroviruses; 1999 May; 15(7):671-7. PubMed ID: 10331446
[TBL] [Abstract][Full Text] [Related]
23. Comparing modified and plain peptide linked enzyme immunosorbent assay (ELISA) for detection of human immunodeficiency virus type-1 (HIV-1) and type-2 (HIV-2) antibodies.
Manocha M; Chitralekha KT; Thakar M; Shashikiran D; Paranjape RS; Rao DN
Immunol Lett; 2003 Feb; 85(3):275-8. PubMed ID: 12663143
[TBL] [Abstract][Full Text] [Related]
24. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
25. Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection.
Loomis-Price LD; Cox JH; Mascola JR; VanCott TC; Michael NL; Fouts TR; Redfield RR; Robb ML; Wahren B; Sheppard HW; Birx DL
J Infect Dis; 1998 Nov; 178(5):1306-16. PubMed ID: 9780250
[TBL] [Abstract][Full Text] [Related]
26. Epitopes of HIV-1 glycoproteins recognized by the human immune system.
Laal S; Zolla-Pazner S
Chem Immunol; 1993; 56():91-111. PubMed ID: 7680869
[No Abstract] [Full Text] [Related]
27. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
Ota A; Tanaka-Taya K; Ueda S
Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
[TBL] [Abstract][Full Text] [Related]
28. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.
McCaffrey RA; Saunders C; Hensel M; Stamatatos L
J Virol; 2004 Apr; 78(7):3279-95. PubMed ID: 15016849
[TBL] [Abstract][Full Text] [Related]
29. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
30. [Peptides from the principal neutralizing and CD4-binding domain: similar immunoreactive properties and structure pattern].
Meshcheriakova DV; Andreev SM; Sidorova MV; Vafina MG; Az'muko AA; Petrukhina AO; Khaitov RM
Vestn Ross Akad Med Nauk; 1992; (9-10):47-52. PubMed ID: 1283721
[TBL] [Abstract][Full Text] [Related]
31. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS
J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841
[TBL] [Abstract][Full Text] [Related]
32. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection.
Turbica I; Simon F; Besnier JM; LeJeune B; Choutet P; Goudeau A; Barin F
J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041
[TBL] [Abstract][Full Text] [Related]
33. Loss of antibody reactivity directed against the V3 domain of certain human immunodeficiency virus type 1 variants during disease progression.
Schreiber M; Wachsmuth C; Müller H; Hagen C; Schmitz H; van Lunzen J
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2403-14. PubMed ID: 8887471
[TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value.
Robert-Guroff M; Roilides E; Muldoon R; Venzon D; Husson R; Marshall D; Gallo RC; Pizzo PA
J Infect Dis; 1993 Mar; 167(3):538-46. PubMed ID: 7680059
[TBL] [Abstract][Full Text] [Related]
35. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
[TBL] [Abstract][Full Text] [Related]
36. Cross-reactivity between autoimmune anti-U1 snRNP antibodies and neutralizing epitopes of HIV-1 gp120/41.
Douvas A; Takehana Y
AIDS Res Hum Retroviruses; 1994 Mar; 10(3):253-62. PubMed ID: 7517148
[TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus type 1-infected patients with no disease progression display high-avidity antibody production to autologous V3 sequences.
Broström C; Sönnerberg A; Sällberg M
J Infect Dis; 1995 Feb; 171(2):509-11. PubMed ID: 7844405
[No Abstract] [Full Text] [Related]
38. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.
Becquart P; Hocini H; Lévy M; Sépou A; Kazatchkine MD; Bélec L
J Infect Dis; 2000 Feb; 181(2):532-9. PubMed ID: 10669336
[TBL] [Abstract][Full Text] [Related]
39. Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping.
Barin F; Lahbabi Y; Buzelay L; Lejeune B; Baillou-Beaufils A; Denis F; Mathiot C; M'Boup S; Vithayasai V; Dietrich U; Goudeau A
AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1279-89. PubMed ID: 8870850
[TBL] [Abstract][Full Text] [Related]
40. Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays.
Zouhair S; Roussin-Bretagne S; Moreau A; Brunet S; Laperche S; Maniez M; Barin F; Harzic M
J Clin Microbiol; 2006 Feb; 44(2):662-5. PubMed ID: 16455942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
